1 tracked superinvestor hold UNITED THERAPEUTICS CORP DEL (UTHR), worth $1.1B combined, led by ex-Jim Simons. Smart money is trimming UTHR as of the latest 13F filings.
Current price
$552.48
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$1.1B
disclosed long exposure
Tier-1 conviction
0
concentrated holders
Net this quarter
-1
0 buying · 1 selling
Smart money is net reducing UTHR: 1 funds trimmed versus 0 adding.
UNITED THERAPEUTICS CORP DEL (UTHR) appears mainly in diversified and quant books here (1 funds, $1.1B combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.
The largest position belongs to ex-Jim Simons at 1.7% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 0 added and 1 trimmed, a net reduction.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Trimmed | 1.7% | $1.1B |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own UTHR?
1 tracked funds hold UNITED THERAPEUTICS CORP DEL (UTHR), the largest being ex-Jim Simons (Renaissance Technologies) at 1.7% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling UTHR?
In the most recent 13F quarter, 0 tracked funds added or opened UTHR and 1 trimmed it.
How much UTHR do tracked funds hold?
Combined disclosed long exposure to UTHR across tracked superinvestors is $1.1B as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.